V I S I T
WORLD’S CLINICAL LABORATORY NEWS LEADER ISSN 1068-1760
Vol.40 No.2 • 4/2023
DAILY CLINICAL LAB NEWS
®
I
N
T
E
Identifying Prediabetics Before Symptoms ype 2 diabetes takes years to develop but is preventable if caught early. However, just 50% of people with prediabetes go on to develop full-blown diabetes over a period of 10 years. Unfortunately, current diabetes tests such as hemoglobin A1C
T
R
N
A
T
I
O
New Method Detects RNA Viruses Faster and More Effectively than PCR n innovative method to detect RNA viruses based on the triplex-forming probe technology paves the way for new options for detecting viruses such as SARS-CoV-2, the influenza A virus (H1N1) or the respiratory syncytial virus (RSV),
A
a pathogen that affects newborn babies and needs careful differential diagnosis. The new methodology, called the Triplex Enhanced Nucleic Acid Detection Assay (TENADA), is based on the ability of polypurine hairpins (PPRHs) designed
Cont’d on page 24
Cont’d on page 15
Innovative Blood Test Poised to Replace Stress Tests, Angiograms revolutionary diagnostic tool called PrecisionCHD offers the first integrated epigenetic-genetic blood test for the early detection of coronary heart disease.
V
I
S
I
T
LINKXPRESS COM R E A D E R
S E R V I C E
®
P O R T A L
Renew/Start your Free Subscription Access Interactive Digital Magazine Instant Online Product Information:
on LinkXpress.com 2 toClick reach reader service portal Mark code(s) of interest on 3 LinkXpress ® inquiry matrix
bump, blow, or whiplash to the head is the main cause of traumatic brain injury (TBI), which can lead to shortand long-term detrimental effects. People affected by TBI may experience impaired memory, movement, sensation (such as hearing and vision), and emotional function (such as psychological symptoms Cont’d on page 4
Unique Biomarker Could Improve Early Alzheimer’s Diagnostics
If your subscription is not renewed every 12 months your Free Subscription may be automatically discontinued
P
rostate cancer is the most common cancer in men. For the first time in 20 years, cases of advanced prostate cancer are on the rise, according to new data from the “Cancer Statistics 2023” report released by The American Cancer Society (ACS). Currently, no single test is available for prostate cancer, although prostate-specific antigen (PSA) blood tests are the
P
lioblastoma (GBM) is a particularly aggressive type of brain cancer with a five-year survival rate of only 5%. Researchers have now identified a biomarker that could be used in blood tests to diagnose GBM, track its progression and guide treatment. This means non-invasive liquid biopsy for GBM could be a great help for patients, allowing them to receive the care they need Cont’d on page 19
INSIDE
A
atients with Alzheimer’s disease experience endothelial injury, or damage to the cells lining the tiny blood vessels in the brain. Previous research has focused on changes visible in brain tissue under a microscope including the beta-amyloid pro-
Test Detects Prostate Cancer at 94% Accuracy
G
First Lab-Based Blood Test for Evaluating Concussions
®
L
Liquid Biopsy Test for Brain Cancer
Image: 3D illustration showing atherosclerosis with atheromatous plaque inside an artery, leading to narrowing of the blood vessel (Shutterstock).
Identify LinkXpress codes of 1 interest as you read magazine
A
Cont’d on page 8
A
See article on page 10
N
tein and another protein, called tau. Beta-amyloid is a naturally occurring protein that clumps together in abnormal levels among patients with Alzheimer’s to form plaques which get collected between neurons and disrupt cell function. Tau is a protein that Cont’d on page 21
Clinical News . . . . . . 4 LabMedica EXPO . 6-20 IFCC News. . . . . . . . 25 Industry News .. . . . 29 Events Calendar. . 30 PUBLISHED IN COOPERATION WITH
International Federation of Clinical Chemistry and Laboratory Medicine
GLOBETECH >>> MEDIA <<<